Murdo Gordon

Murdo Gordon co-leads the Bristol-Myers Squibb Commercial organization and is head of Worldwide Markets. In this role, he has operational responsibility for each of the markets and regions where Bristol-Myers Squibb conducts business. Murdo works closely with country and regional general managers and their local teams to maximize the impact our products have on the lives of patients.

“BMS is fundamentally transforming the way cancer and other diseases are treated across the globe,” says Murdo. “The Commercial organization must move quickly to communicate the science of our products to payers, health care professionals and patients and help them fight their disease.”

Murdo joined Bristol-Myers Squibb in 1989. He spent the first 14 years of his career in Canada where he held positions of increasing responsibility in sales and marketing. Murdo moved to the U.S. in 2003, where he worked in a number of different therapeutic areas such as cardiovascular, neuroscience, Access/Government Affairs, Oncology and Immunology as well as president of Bristol-Myers Squibb in the U.S.

Murdo is a member of the Board of Directors of Robert Wood Johnson University Hospital System. He maintains an active interest in global and U.S. health care policy and how different stakeholders can improve the efficiency and cost effectiveness of health care delivery.

Murdo received a BSc in Cell and Molecular Biology from Concordia University, Montreal, and also attended the General Management Program, CEDEP at INSEAD, Fontainebleau, France.

May 2015